US EditionAtorvastatin and the Fight Against High Cholesterol: A Lifesaving Drug for Millions
- Atorvastatin, approved in 1996 and initially sold as Lipitor, is a widely used medication for managing high cholesterol to prevent heart attacks and strokes.
- Millions develop cholesterol disorders, a leading risk factor for cardiovascular diseases, prompting statins like atorvastatin as first-line treatments.
- Atorvastatin became the world's bestselling drug in the 2000s, with over 40 million U.S. Prescriptions filled annually and broad adoption in primary prevention.
- Clinical trials show atorvastatin reduces cardiovascular events by up to 36%, and generic versions now cost as little as $5 to $15 monthly, increasing accessibility.
- The effectiveness and cost-accessibility of atorvastatin have played a key role in significantly lowering deaths from cardiovascular disease over the last twenty years, continuing to be essential in worldwide efforts to prevent heart-related conditions.
11 Articles
11 Articles
Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
Higher concentrations of cholesterol-containing low-density lipoprotein (LDL-C) increase the risk of cardiovascular disease (CVD). The association of LDL-C with non-CVD traits remains unclear, as are the possible independent contributions of other cholesterol-containing lipoproteins and apolipoproteins. Nuclear magnetic resonance spectroscopy was used to measure the cholesterol content of high density (HDL-C), very low-density (VLDL-C), intermed…
InsideNoVA.com
Atorvastatin and the fight against high cholesterol: A lifesaving drug for millions
SaveHealth provides an in-depth look at cholesterol-fighting atorvastatin, its mechanism of action, clinical significance, and its impact in combating one of the most pervasive chronic health conditions of modern times.
Scientists hail 'revolutionary' drug shown to slash bad cholesterol by 69% in a single dose
A single injection of an experimental drug called VERVE-102 can lower cholesterol levels by up to 69 per cent, according to initial clinical trial results that have not yet been peer reviewed. The treatment could transform heart attack prevention by dramatically reducing LDL cholesterol - the so-called 'bad' cholesterol - with just one injection.While statins can achieve similar cholesterol reductions, they generally need to be taken daily. VERV…
Coverage Details
Bias Distribution
- 90% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage